Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions

Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions

Bibliographic Details
Main Authors: Amee D Pandya, Dhaiwat Shukla, Supriya D Malhotra, Pankaj Patel, Sapan Pandya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Rheumatology
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=251;epage=253;aulast=Pandya
id doaj-269b0d4f1fb846d4bd2e7a64e7cb12b0
record_format Article
spelling doaj-269b0d4f1fb846d4bd2e7a64e7cb12b02020-11-25T01:17:01ZengWolters Kluwer Medknow PublicationsIndian Journal of Rheumatology0973-36980973-37012019-01-0114325125310.4103/injr.injr_94_19Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusionsAmee D PandyaDhaiwat ShuklaSupriya D MalhotraPankaj PatelSapan Pandyahttp://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=251;epage=253;aulast=Pandya
collection DOAJ
language English
format Article
sources DOAJ
author Amee D Pandya
Dhaiwat Shukla
Supriya D Malhotra
Pankaj Patel
Sapan Pandya
spellingShingle Amee D Pandya
Dhaiwat Shukla
Supriya D Malhotra
Pankaj Patel
Sapan Pandya
Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
Indian Journal of Rheumatology
author_facet Amee D Pandya
Dhaiwat Shukla
Supriya D Malhotra
Pankaj Patel
Sapan Pandya
author_sort Amee D Pandya
title Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
title_short Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
title_full Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
title_fullStr Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
title_full_unstemmed Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
title_sort tocilizumab-induced anaphylactic reactions in rheumatic diseases: consideration for clinicians with monoclonal antibody infusions
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Rheumatology
issn 0973-3698
0973-3701
publishDate 2019-01-01
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=251;epage=253;aulast=Pandya
work_keys_str_mv AT ameedpandya tocilizumabinducedanaphylacticreactionsinrheumaticdiseasesconsiderationforclinicianswithmonoclonalantibodyinfusions
AT dhaiwatshukla tocilizumabinducedanaphylacticreactionsinrheumaticdiseasesconsiderationforclinicianswithmonoclonalantibodyinfusions
AT supriyadmalhotra tocilizumabinducedanaphylacticreactionsinrheumaticdiseasesconsiderationforclinicianswithmonoclonalantibodyinfusions
AT pankajpatel tocilizumabinducedanaphylacticreactionsinrheumaticdiseasesconsiderationforclinicianswithmonoclonalantibodyinfusions
AT sapanpandya tocilizumabinducedanaphylacticreactionsinrheumaticdiseasesconsiderationforclinicianswithmonoclonalantibodyinfusions
_version_ 1725148838319095808

Similar Items